Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
research laboratory
|
| gptkbp:analyzes |
tumor suppressor genes
|
| gptkbp:collaboratesWith |
pharmaceutical companies
various institutions |
| gptkbp:conducts |
high-throughput screening
|
| gptkbp:contributedTo |
understanding of cancer biology
|
| gptkbp:develops |
therapeutic strategies
|
| gptkbp:engagesIn |
biomedical research
|
| gptkbp:focusesOn |
genetics
cell biology cancer research |
| gptkbp:hasAccessTo |
state-of-the-art equipment
|
| gptkbp:hasCollaboratedWith |
gptkb:Johns_Hopkins_University
gptkb:Stanford_University gptkb:MIT |
| gptkbp:hasDeveloped |
new diagnostic tools
|
| gptkbp:hasEstablished |
international collaborations
|
| gptkbp:hasEvents |
significant breakthroughs
|
| gptkbp:hasMember |
graduate students
postdoctoral researchers research technicians |
| gptkbp:hasPublications |
over 200 research papers
|
| gptkbp:hosts |
visiting scientists
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elledge Lab
|
| gptkbp:isActiveIn |
community outreach
research collaborations |
| gptkbp:isEngagedIn |
publications in high-impact journals
|
| gptkbp:isFocusedOn |
translational research
|
| gptkbp:isInvolvedIn |
clinical trials
collaborative projects mentoring young scientists |
| gptkbp:isKnownFor |
its interdisciplinary approach
innovative research techniques |
| gptkbp:isLocatedIn |
gptkb:Boston,_Massachusetts
|
| gptkbp:isPartOf |
gptkb:Harvard_University
the_Harvard_Medical_School_community |
| gptkbp:isRecognizedFor |
its contributions to science
|
| gptkbp:isSupportedBy |
grants
|
| gptkbp:ledTo |
gptkb:Stephen_Elledge
|
| gptkbp:locatedIn |
gptkb:Harvard_Medical_School
|
| gptkbp:offers |
internship opportunities
|
| gptkbp:participatesIn |
scientific conferences
|
| gptkbp:promotes |
scientific education
|
| gptkbp:provides |
training in molecular biology
|
| gptkbp:publishedIn |
scientific journals
|
| gptkbp:receivesFundingFrom |
NIH
private foundations |
| gptkbp:research |
cellular signaling pathways
|
| gptkbp:utilizes |
CRISPR technology
|